Two Sigma Advisers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-392,700
| Closed | -$159M | – | 2635 |
|
|
2025
Q2 | $159M | Sell |
392,700
-136,500
| -26% | -$57.1M | 0.33% | 65 |
|
|
2025
Q1 | $263M | Sell |
529,200
-404,000
| -43% | -$219M | 0.59% | 36 |
|
|
2024
Q4 | $485M | Buy |
933,200
+419,200
| +82% | +$230M | 1.12% | 15 |
|
|
2024
Q3 | $318M | Buy |
514,000
+135,300
| +36% | +$80.1M | 0.74% | 32 |
|
|
2024
Q2 | $209M | Buy |
378,700
+337,100
| +810% | +$193M | 0.47% | 47 |
|
|
2024
Q1 | $24.2M | Buy |
41,600
+27,100
| +187% | +$15.2M | 0.06% | 303 |
|
|
2023
Q4 | $7.7M | Buy |
14,500
+8,800
| +154% | +$4.26M | 0.02% | 639 |
|
|
2023
Q3 | $2.89M | Sell |
5,700
-98,600
| -95% | -$52.5M | 0.01% | 1002 |
|
|
2023
Q2 | $54.4M | Buy |
104,300
+36,200
| +53% | +$19.5M | 0.14% | 164 |
|
|
2023
Q1 | $39.3M | Buy |
+68,100
| New | +$38.4M | 0.1% | 202 |
|
|
2022
Q3 | – | Sell |
-8,100
| Closed | -$4.4M | – | 2729 |
|
|
2022
Q2 | $4.4M | Sell |
8,100
-18,000
| -69% | -$9.91M | 0.01% | 834 |
|
|
2022
Q1 | $15.4M | Sell |
26,100
-409,400
| -94% | -$235M | 0.04% | 385 |
|
|
2021
Q4 | $291M | Buy |
435,500
+429,600
| +7,281% | +$268M | 0.73% | 31 |
|
|
2021
Q3 | $3.37M | Buy |
5,900
+4,700
| +392% | +$2.58M | 0.01% | 973 |
|
|
2021
Q2 | $605K | Buy |
+1,200
| New | +$566K | ﹤0.01% | 1856 |
|
|
2020
Q4 | – | Sell |
-700
| Closed | -$309K | – | 2590 |
|
|
2020
Q3 | $309K | Buy |
+700
| New | +$289K | ﹤0.01% | 1996 |
|
|
2020
Q2 | – | Sell |
-80,300
| Closed | -$22.8M | – | 2606 |
|
|
2020
Q1 | $22.8M | Buy |
+80,300
| New | +$25.3M | 0.09% | 265 |
|
|
2019
Q2 | – | Sell |
-3,403
| Closed | -$931K | – | 2437 |
|
|
2019
Q1 | $931K | Sell |
3,403
-26,200
| -89% | -$6.52M | ﹤0.01% | 1563 |
|
|
2018
Q4 | $6.63M | Buy |
+29,603
| New | +$6.95M | 0.02% | 701 |
|
|
2018
Q3 | – | Sell |
-3,121
| Closed | -$646K | – | 2400 |
|
|
2018
Q2 | $646K | Sell |
3,121
-7,900
| -72% | -$1.68M | ﹤0.01% | 1816 |
|
|
2018
Q1 | $2.27M | Sell |
11,021
-15,100
| -58% | -$3.17M | 0.01% | 1189 |
|
|
2017
Q4 | $4.96M | Sell |
26,121
-111,200
| -81% | -$21.3M | 0.01% | 845 |
|
|
2017
Q3 | $26M | Buy |
137,321
+59,901
| +77% | +$10.8M | 0.07% | 301 |
|
|
2017
Q2 | $13.5M | Sell |
77,420
-53,801
| -41% | -$9.04M | 0.04% | 431 |
|
|
2017
Q1 | $20.2M | Sell |
131,221
-772,536
| -85% | -$118M | 0.07% | 359 |
|
|
2016
Q4 | $128M | Buy |
903,757
+503,690
| +126% | +$74.3M | 0.49% | 44 |
|
|
2016
Q3 | $63.6M | Buy |
400,067
+397,390
| +14,845% | +$61.2M | 0.27% | 92 |
|
|
2016
Q2 | $396K | Buy |
+2,677
| New | +$395K | ﹤0.01% | 1612 |
|
|
2015
Q2 | – | Sell |
-67,683
| Closed | -$9.09M | – | 2073 |
|
|
2015
Q1 | $9.09M | Buy |
67,683
+17,900
| +36% | +$2.31M | 0.07% | 337 |
|
|
2014
Q4 | $6.24M | Buy |
+49,783
| New | +$6.05M | 0.05% | 423 |
|
|
2014
Q2 | – | Sell |
-14,783
| Closed | -$1.78M | – | 2691 |
|
|
2014
Q1 | $1.78M | Buy |
14,783
+6,800
| +85% | +$808K | 0.02% | 830 |
|
|
2013
Q4 | $889K | Buy |
+7,983
| New | +$794K | 0.01% | 1199 |
|
Other funds holding TMO
Two Sigma Advisers's TMO Position: Q3 2025 in Review
Two Sigma Advisers sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 392,700 shares — an estimated $159M sold.
Two Sigma Advisers first reported a position in TMO in Q4 2013 and held it in 32 quarters. The position peaked at $485M in Q4 2024. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- Two Sigma Advisers reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
- Two Sigma Advisers sold 392,700 Thermo Fisher Scientific shares in Q3 2025, an estimated $159M.
- Two Sigma Advisers first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 32 quarters.
- Two Sigma Advisers's Thermo Fisher Scientific position peaked at $485M in Q4 2024.
- 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.